1. Home
  2. PMVP vs VIDA Comparison

PMVP vs VIDA Comparison

Compare PMVP & VIDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

SELL

Current Price

$1.26

Market Cap

72.2M

Sector

Health Care

ML Signal

SELL

VIDA

VIDA Global Inc. Class A Common Stock

SELL

Current Price

$0.69

Market Cap

64.7M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
PMVP
VIDA
Founded
2013
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
72.2M
64.7M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
PMVP
VIDA
Price
$1.26
$0.69
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $4.00
N/A
AVG Volume (30 Days)
★ 368.4K
56.5K
Earning Date
11-10-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.70
52 Week High
$1.91
$4.25

Technical Indicators

Market Signals
Indicator
PMVP
VIDA
Relative Strength Index (RSI) 45.55 25.15
Support Level $1.24 N/A
Resistance Level $1.49 $1.19
Average True Range (ATR) 0.09 0.13
MACD -0.00 0.01
Stochastic Oscillator 28.30 3.80

Price Performance

Historical Comparison
PMVP
VIDA

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: